Cargando…

CD47 on artificial structures

Detalles Bibliográficos
Autor principal:	Schütz, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586089/ https://www.ncbi.nlm.nih.gov/pubmed/26298418

Ejemplares similares

47th Annual Meeting of the EBMT
por: del Pozo Martín, Yaiza
Publicado: (2021)

Telemedicine in Neurosurgery and Artificial Intelligence Applications
por: Paro, Mitch R., et al.
Publicado: (2022)

DIET AND NUTRITION: The Artificial Food Dye Blues
por: Potera, Carol
Publicado: (2010)

News and Views (3 & 4): JPS Young Scientist Award, 47th AAPPS Council Meeting
Publicado: (2022)

Structure of the human marker of self 5-transmembrane receptor CD47
por: Fenalti, Gustavo, et al.
Publicado: (2021)

CD99: An endothelial passport for leukocytes
por: Hickey, Michael J.
Publicado: (2015)

CD44's nuclear road trip
por: Leslie, Mitch
Publicado: (2009)

COVID-19 and artificial intelligence: protecting health-care workers and curbing the spread
por: McCall, Becky
Publicado: (2020)

CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016)

Role of CD47 in Hematological Malignancies
por: Eladl, Entsar, et al.
Publicado: (2020)

Targeting CD47 for cancer immunotherapy
por: Jiang, Zhongxing, et al.
Publicado: (2021)

CD81 as target for B cell lymphomas
por: Küppers, Ralf
Publicado: (2019)

A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
por: Betancur, Paola A., et al.
Publicado: (2017)

CD9: A possible clue into breast cancer chemoresistance
por: Pacienza, Natalia, et al.
Publicado: (2019)

Significance of CD47 expression in gastric cancer
por: Sudo, Tomoya, et al.
Publicado: (2017)

Regulation of CD47 expression in cancer cells
por: Huang, Can-Yu, et al.
Publicado: (2020)

CD47 (Cluster of differentiation 47): an anti-phagocytic receptor with a multitude of signaling functions
por: Leclair, Pascal, et al.
Publicado: (2020)

CD47 cross-dressing by extracellular vesicles expressing CD47 inhibits phagocytosis without transmitting cell death signals
por: Li, Yang, et al.
Publicado: (2022)

Dissecting neurotransmission with artificial synapses
por: Short, Ben
Publicado: (2021)

Prospects of antibodies targeting CD47 or CD24 in the treatment of glioblastoma
por: Wu, Hao, et al.
Publicado: (2021)

Effective effector generation of CD8(+) T cells and NK cells: A need for T-bet and ZEB-too
por: Hamilton, Sara E., et al.
Publicado: (2015)

Upregulation of CD47 in Regulatory T Cells in Atopic Dermatitis
por: Lee, Nara, et al.
Publicado: (2016)

Is CD47 an innate immune checkpoint for tumor evasion?
por: Liu, Xiaojuan, et al.
Publicado: (2017)

Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
por: Petralia, Maria Cristina, et al.
Publicado: (2019)

CD47 prevents the elimination of diseased fibroblasts in scleroderma
por: Lerbs, Tristan, et al.
Publicado: (2020)

CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation
por: Okunuki, Yoko, et al.
Publicado: (2021)

Cancer Therapy Targeting CD47/SIRPα
por: Dizman, Nazli, et al.
Publicado: (2021)

CD47 as a promising therapeutic target in oncology
por: Zhao, Hai, et al.
Publicado: (2022)

Checkpoint CD47 expression in classical Hodgkin lymphoma
por: Gholiha, Alex Reza, et al.
Publicado: (2022)

Autoimmune TCR structure
por: LeBrasseur, Nicole
Publicado: (2005)

Synaptic vesicle structure
por: Wells, William A.
Publicado: (2006)

Structure of the meiotic spindle
por: Sedwick, Caitlin
Publicado: (2007)

No crystal structure? No problem
por: Leslie, Mitch
Publicado: (2012)

PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses
por: Song, Shilong, et al.
Publicado: (2019)

The identification of a CD47-blocking “hotspot” and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination
por: Shi, Rui, et al.
Publicado: (2020)

Structure with a light touch
por: Wells, William A.
Publicado: (2004)

Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis
por: Hendriks, Mark A.J.M., et al.
Publicado: (2021)

Can artificial intelligence identify effective COVID‐19 therapies?
por: Schultz, Michael B, et al.
Publicado: (2020)

Artificial optical synaptic devices with ultra-low power consumption
por: Li, Guoqiang
Publicado: (2023)

CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis
por: Kojima, Yoko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_19vvdvgb51311g17j990t1ntlg